Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 466 to 480 of 489 results for %s

  1. Past research and projects

    NICE's past research and projects

  2. NICE responds to publication of the government's Life Sciences Sector Plan

    We welcome the publication of the government's Life Sciences Sector Plan, which sets out how NICE will ensure patients get faster, fairer access to transformative new medicines and life-changing healthtech, while supporting a thriving life sciences industry in the UK.

    News
    Last updated
    16 July 2025

  3. Join our people and communities network

    Join NICE's people and communities network

  4. Patient and public involvement policy

    Read NICE's patient and public involvement policy.

  5. Contact us

    To contact us, NICE's website is usually the quickest way to find the answer to a query.

  6. Freedom of information

    NICE's Freedom of Information Act 2000 provides a right of access to recorded information held by public authorities.

  7. Key question: caring

    This resource is intended to demonstrate how our guidance can be used in the Care Quality Commission (CQC) assessment process.

  8. Data collection agreement

    NICE's external assessment centre. 1.3 The NICE health technology appraisal(s) of lumacaftor/ivacaftor, tezacaftor/ivacaftor and...

  9. Key question: effective

    This resource is intended to demonstrate how our guidance can be used in the Care Quality Commission (CQC) assessment process.

  10. Key question: responsive

    This resource is intended to demonstrate how our guidance can be used in the Care Quality Commission (CQC) assessment process.

  11. Key question: safe

    This resource is intended to demonstrate how our guidance can be used in the Care Quality Commission (CQC) assessment process.

  12. Cost saving, resource planning and audit

    NICE's guidance and advice can help you make the best use of resources and generate cost savings.

  13. NICE leads the way in approving breakthrough treatment for multiple myeloma

    People in England will become the first in the world to receive belantamab mafodotin for this indication following our recommendation and the UK's Medicines and Healthcare products Regulatory Agency (MHRA) approval earlier this year.

    News
    Last updated
    13 June 2025

  14. Stage 2: clinical assessment

    In a virtual ward setting, you make assessments at home to support clinical decision-making. Our guidance can help you give advice by highlighting areas to consider and standards of care.

  15. Study NICE and LSE's Executive MSc Healthcare Decision-Making

    Study NICE and LSE's Executive MSc Healthcare Decision-Making